Goldline Pharmaceutical Ltd (544759) — Voting Results | 31 August 2026

· BSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
All 8 resolutions passed with 100% approval in AGM voting.
💡 Investor Takeaway
Shareholders approved all proposals, confirming board continuity and transaction approvals.

Goldline Pharmaceutical held its AGM on 29 August 2026, appointing CS Avinash Gandhewar as scrutinizer. All 8 resolutions passed with 100% approval across remote e-voting and ballot polling, including re-appointment of directors and approval of related party transactions. The company confirmed valid voting records and no invalid votes impacted outcomes.

📄 View Original Announcement (PDF)

About Goldline Pharmaceutical Ltd (544759)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹39.26 Cr

View full 544759 stock details →

📡 Get AI alerts when 544759 files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track 544759 — Free

📊 More 544759 filings

See all 544759 filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts for your stocks — summarized by AI daily

Set up your AI Radar — pick stocks, get daily email summaries of new filings.

Set up AI Radar — Free

Free account · 2 AI queries/day